Goldman Sachs Upgrades Eli Lilly (LLY) to Neutral
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $724.87 -1%
Rating Summary:
25 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
25 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Goldman Sachs upgraded Eli Lilly (NYSE: LLY) from Sell to Neutral with a price target of $70.00 (from $65.00).
Analyst Jami Rubin said, "We upgrade LLY from Sell to Neutral based on the increased optionality provided by cost reduction, new product launches and pipeline assets."
For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.
Shares of Eli Lilly closed at $69.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck (MRK) PT Raised to $143 at Truist Securities
- HSBC Upgrades UPS (UPS) to Buy, 'Back to earnings growth'
- Amazon.com (AMZN) PT Raised to $215 at UBS
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT Change, UpgradesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
